Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
about
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureAdipocytokines and obesity-linked disordersAdipokines in inflammation and metabolic diseaseAdiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial DysfunctionAdiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice.Placental growth factor mediates aldosterone-dependent vascular injury in mice.Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction.Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes.Neuronal nitric oxide synthase inhibition improves diastolic function and reduces oxidative stress in ovariectomized mRen2.Lewis ratsCardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptorAdiponectin in cardiovascular inflammation and obesityAdiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity.Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasisC1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heartRenin-Angiotensin Activation and Oxidative Stress in Early Heart Failure with Preserved Ejection Fraction.Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection FractionLow adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromsø Study.Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.Association between adiponectin and heart failure risk in the physicians' health study.Aldosterone and cardiovascular disease: the heart of the matter.Association of low plasma adiponectin with early diastolic dysfunctionFollistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection FractionAdipokines: a link between obesity and cardiovascular disease.Adiponectin and hypertension.The role of adiponectin signaling in metabolic syndrome and cancer.Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats.Inflammation - Cause or Consequence of Heart Failure or Both?Can Adiponectin Help us to Target Diastolic Dysfunction?Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin.Preoperative left ventricular hypertrophy is associated with reduced patient survival after liver transplantation.Decreased plasma adiponectin is associated with impaired left ventricular longitudinal systolic function in hypertensive patients: a two-dimensional speckle tracking study.Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.In hemodialysis, adiponectin, and pro-brain natriuretic peptide levels may be subjected to variations in body mass index.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".
P2860
Q26745026-C8D2EF7F-14A6-4B05-98F5-915F21341117Q27021977-7393C9E6-DB75-43A7-A374-D99BB4678549Q29620456-37909C3B-0A8E-48F7-B474-D7A1B4C6FA54Q33839167-38FA8BCC-5413-4BF5-A68B-72D6C8B2CB07Q33910404-115450D2-8219-473D-8047-73E3BB2218F5Q34245292-12C38D9D-0794-4EEB-9406-F862DABD5925Q34559877-D2952E0E-E670-4A20-B025-02A167D73BE4Q34697156-E41F273F-BD12-4EF9-941B-099FE5471924Q34873021-1FE4419F-5742-492B-8263-BC6C72E7A291Q35068845-5E470BFB-0C10-48D2-8158-F6BFC4580A64Q35071304-97A8A518-EE23-42D1-8B38-77B3B0E750C5Q35219362-C9850218-1BD6-4C15-AB7D-E62204375BC1Q35315318-407825F8-502E-4025-B664-BB76617865C8Q35510385-1B56B616-25C5-447C-B21F-8FE86102853FQ35882942-6D2CBA9B-BE23-4AA4-98FD-C775A90444A1Q35916840-3B6EA3E5-3E9E-49B6-BF45-8DFD2231D6F1Q36074375-322BBF6A-CAAD-46D8-9B07-64CB76C638FBQ36080823-F20D5811-0197-4654-9256-A7E8DDCCB743Q36172961-D89CF842-43E9-448E-9658-0DA29AF870E1Q36181771-41946707-5377-4682-8EF6-BBD6CEF028A6Q36307705-CC59BDA8-80DD-4E4C-826D-0540054F00F0Q36309316-DF6B3223-F81E-4790-8E6B-C7FB55DFD7DEQ36341930-2691E44E-2EBB-4AB5-92DE-621C0FD225A2Q36494721-DA6A9EED-C92F-476E-AE26-871A6FCD27F8Q36821968-4710AB03-9304-4064-A43F-1D6D45B2ADE2Q37094365-8A649B59-3542-4A16-A90A-E026EAD33072Q37707281-F5D2C394-B26E-4C00-A00E-8FA3BC465E67Q37798714-893DD9F8-3EF2-4A1C-B39B-671C7E7C9CC8Q38135763-F9B25FC3-F94E-43AC-A596-9CA9AAD1D19AQ38427655-42D8C484-9AF2-4222-ABBC-E314AFEA43A8Q38664204-4F507B52-3418-4E36-B4CB-30302647AFF6Q38984959-8904CC20-D5CB-4C10-A0D9-A0F4D72F2E03Q41925406-EE2A618A-4B06-4418-BE1A-AC733E0055C8Q45937752-2E0DF46E-BD4C-4F4F-AF1D-2034E266BCDBQ46088350-5FB955A0-7E03-4105-ACA9-351395E60AF7Q47110057-BC952CCA-0921-42D5-937C-ACDBAC7A0111Q48951387-DCD142C7-25DC-43BA-B78A-4622C60AA05AQ49203906-3A6E9D1A-736F-4F6D-ABEB-8492D88D5A6F
P2860
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@ast
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@en
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@nl
type
label
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@ast
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@en
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@nl
prefLabel
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@ast
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@en
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@nl
P2093
P2860
P356
P1433
P1476
Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
@en
P2093
Akiko Higuchi
Deepa S De Silva
Kaori Sato
Kenneth Walsh
Koji Ohashi
Noriyuki Ouchi
Richard M Wilson
Saki Sono-Romanelli
Toni-Ann S Duhaney
P2860
P304
P356
10.1210/EN.2009-0806
P407
P577
2009-10-22T00:00:00Z